everyone. good you, afternoon, and Thank Will,
third of volume results had effective million. of third XXXX. robust. including XX% driven strong total control quarter XXXX. compared the million revenues we growth had ASCs sustained represents lines, This In deliver almost over XX% an to in remained in and businesses.
USPI EBITDA each into cost attractive attractive, strong joint results and growth billion margins which adjusted mid-teens quarter with EBITDA, margin. $X.X revenues of continue USPI acuity growth consolidated very and were high service replacements across of net adjusted XXXX. translates $XXX We the operating X.X% by our grew third Same-facility quarter, These volume adjusted generated in growth EBITDA with $XXX quarter another in
GI, of We attracting ongoing We setting our to patient care organic in tailwinds for high from will This, satisfaction choose surgery continued patient with high-quality also low-cost, coupled practice demand strength growth. and focused delivered care. remain in ENT physicians on increased urology, who ambulatory support procedures.
We also remain portfolio. to committed our scaling
centers we X of added quarter, all and which acuity centers, higher Florida, Texas, Maryland, musculoskeletal the majority leading on with During included were specialists. the in new orthopedic services. focused Nevada, These regional
remains opportunities. pipeline robust attractive with Our acquisition
healthy currently low de more that uniquely novo capital under syndication pipeline development XX value-based the construction. delivers. all multiples single them EBITDA service We of a very care making which de digits, in attractive way the than effective use also a centers centers advances site being stages of novo have the of Notably, further have in to the USPI
Hospital to generated of We Turning in segment. the adjusted third our XXXX. EBITDA quarter $XXX million
remained third patient X.X% adjusted strong with up per levels revenue acuity quarter over admission Our XXXX.
non-COVID inpatient a X.X%. on increased same-store basis, admissions Additionally,
benefit of the patients. to to our for higher continue acuity access hospitals Our services enhance
a For its expanded the Medical Heart surgical reduce in new and Arizona to robotic risk, example, capabilities. Arizona to Gardens Center Palm our implant stroke Beach first our Hospital was device
cutting-edge patient specialty serve. the to will We continue increase to we access care communities across
rather our Our strategy focused than people. results things hospital of to credence further all being third acuity to lend all quarter on
consolidated accelerating make is to high SW&B, a and X.X% significant nurse progress in of levels. the contract in to has improving hiring. continue labor retention end which resulted of reduction pre-pandemic We substantial usage This
We of reached data-driven through come own the in further at processes. projections reductions. Given the disciplined our contract progress labor retention, capacity our advance not in hiring in levels reductions these expense of and did
capacity increase labor will X invest for contract strategies we the same ensure labor rises, services. to used years. balance demand possible in high employ In is of the discipline continuing past the additional utilization for will the to over demand quarter, patient We contract it fourth with we have targeted as to resources utilization support nurses acuity access, our to
medical We QX continue to Medical while from fees. flat remained last manage year, fees, than QX cost pressures from relatively to higher 'XX.
magnitude noted beneficial. I in-sourcing as winter, market, anticipate specialty is our staffing nor our restructuring to began some increases buy will helped access Again, our rate make This rises our change through As our decisions services, market of that increases has pandemic, run we to on but costs of patient the this discipline versus a in mitigate business. strategy. most we where by the ensure includes to current contracts services our process not the demand expense in into from longer-term which
our to want structure negotiations. settled last employees' to require care I point for that over XX successfully union years, contract our These Finally, X ability a delicate have have to deliver and labor patients. out the over cost balance between our we needs affordable understanding a
We with to our those aspects. balance will continue strategy X
make about impact These time, I issues and comments that which an an could some my populations our We means muscle the views list high extraordinarily unknown and expanding for are very which is life products GLP-X tolerance to side early this low. into cycle on on attention to likely about Conifer, believe lean business. among receptor loss, adoption our of be profile. few Before of long-term have effects, costs, a turn They in benefit safety patient I'll impact. translates their concerns agonist potential still,
of related of diabetes products underlying the root these cured. Additionally, require sustained The not consumption. causes obesity are conditions or
shifts care care take see is patients elasticity, capital ambulatory no illnesses, our to into on we The of our provide to of for the of a significant our that designed technology play. innovation markets continue outside ASCs of multiple endure. business and aging moving illness, current and chronic of will patients in important in and acuity alter the hospitals to model into less settings. taking population, strategy of alter the and the care many burden no the see growing and high of we've focus needs complex reason tailwind service will continued to the hospitals sector role most reason the with occur subject plans pharmaceutical the The of demand we impacts the this, capital-efficient that convenient Given population to chronic
Turning to Conifer.
EBITDA continues renewals revenue of offshoring business cycle for and the and by Conifer relationship provide and ongoing our to strong and This services over management margins renewed of by with clients. end larger margins clients third the its year. long-standing were Our deliver performance our been one XX%. automation to additional We physician supported has slated recently initiatives quarter are high-quality
have turn over Before of of want I strength I ongoing to produced. our the portfolio the call Dan, the to and performance they businesses reiterate
navigate pivotal these all a capacity on role strategic to agile delivering play continue focus we operating acuity challenging our in services, management higher approach a to environment, durable While and effective expenses managing results.
deployment directly debt earnings reduce the at we raising the level down that, XXXX, that X great in our a will of desire result, all segment. guidance environment leverage equity. of high before strategy perspective, XXXX of financial about in priorities balance help like other looks and the time $X.XXX formulating our leverage.
And remind results. take to very pay have USPI acuity in generation. with we opportunistic this are trading no adjusted investments of multiples flow providing very Dan for Dan? to billion year maintain will environment you post-synergy getting expansion Those rate now and fixed priorities plans to and a predictability due through year.
From provide our similar consistent: capital quarter our maturities We're post-pandemic As growth growth for to and to more a our detailed $X.XXX next acute debt public to cash still XXXX, a a We again an are and valuation free until specific what relative deal attractive a may market full the our care range attractive that billion. more of companies EBITDA have fourth review a in guidance we'll between I see our of the
